Language

English

Publication Date

7-1-2026

Journal

Pediatric Blood & Cancer

DOI

10.1002/1545-5017.70387

PMID

42084208

PMCID

PMC13331275

PubMedCentral® Posted Date

7-4-2026

PubMedCentral® Full Text Version

Author MSS

Abstract

Treatment-associated hepatotoxicity (TAH) is a common complication of pediatric acute lymphoblastic leukemia (ALL) treatment, but genetic risk factors remain poorly understood. We evaluated the SOD2 rs4880 variant in 544 children with ALL at Texas Children’s Hospital. After adjusting for demographic and clinical covariates, the rs4880 C allele was associated with an increased odds of conjugated hyperbilirubinemia and/or Grade 4 transaminitis in Hispanic children (adjusted odds ratio [aOR] = 2.73, 95% confidence interval [CI]: 1.72–4.47; p = 3.5 × 10−5), but decreased odds in non-Hispanic children (aOR = 0.55, 95% CI: 0.32–0.94, p = 0.03). These findings highlight potential ethnicity-specific differences in genetic contributors to TAH risk and highlight the need for mechanistic studies.

Keywords

Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Female, Male, Superoxide Dismutase 2, Child, Chemical and Drug Induced Liver Injury, Child, Preschool, Superoxide Dismutase, Polymorphism, Single Nucleotide, Adolescent, Infant, Ethnicity, Prognosis, Risk Factors, acute lymphoblastic leukemia, hepatotoxicity, pediatric oncology

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.